NEXT GENERATION SEQUENCING PANEL FOR FAMILIAL HYPERCHOLESTEROLEMIA AND WHOLE EXOME SEQUENCING LIBRARY PREP SOLUTION

Quick Actions

As a subscriber you can save this tender or set notifications for updates.

Description

The contract is for the provision of a Next Generation Sequencing (NGS) panel, associated reagents, technical support, training and related services to support diagnostic testing for Familial Hypercholesterolaemia (FH) within the All Wales Genomics Laboratory. Nonacus is the sole supplier capable of providing the required proprietary panel and associated services, which have been extensively validated within the existing diagnostic pathway. The solution is fully compatible with current laboratory infrastructure and includes ongoing technical support, quality assurance and contingency arrangements to support continuity of service delivery. The service supports approximately 600 diagnostic tests per annum, including initial and cascade testing, as part of the nationally commissioned All Wales Familial Hypercholesterolaemia service.

Award Detail

CPV Codes

• None found

Legal Justification

The required Next Generation Sequencing (NGS) panel incorporates proprietary design, content and associated intellectual property rights that are owned and controlled exclusively by the supplier. No other economic operator is authorised to manufacture, supply, licence or support the specific panel required. The intellectual property protections and exclusive rights prevent equivalent products from being supplied by alternative providers. The required solution has been extensively validated within the existing diagnostic pathway and is fully compatible with current laboratory equipment, workflows and reporting processes. No alternative supplier can provide an equivalent validated solution without significant revalidation, implementation effort and associated costs. Introducing an alternative product would require extensive analytical and clinical validation, resulting in delays to service delivery, additional resource requirements and potential risks to continuity of patient testing. The technical characteristics, proven performance and integration requirements mean that competition is absent for technical reasons.

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. **

Reference

• ocds-h6vhtk-06d3d0
• FTS 070538-2026

Domains

• nwssp.nhs.wales
• nonacus.com
• legislation.gov.uk
• find-tender.service.gov.uk
• wales.nhs.uk